Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Pollak

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of the American Academy of Dermatology|May 10, 2015
Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studiesBoni E Elewski, Raza Aly, Sheryl L Baldwin, et al.
Journal of the American Academy of Dermatology|November 27, 2012
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studiesBoni E Elewski, Phoebe Rich, Richard Pollak, et al.
Journal of the American Podiatric Medical Association|September 22, 2006
Analgesic efficacy of valdecoxib for acute postoperative pain after bunionectomyRichard Pollak, Gary A Raymond, Richard M Jay, et al.
Vaccine|March 26, 2016
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trialGuy de Bruyn, Jamshid Saleh, David Workman, et al.
The New England Journal of Medicine|August 15, 2014
Efficacy of high-dose versus standard-dose influenza vaccine in older adultsCarlos A DiazGranados, Andrew J Dunning, Murray Kimmel, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of the American Academy of Dermatology|May 10, 2015
Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studiesBoni E Elewski, Raza Aly, Sheryl L Baldwin, et al.
Journal of the American Academy of Dermatology|November 27, 2012
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studiesBoni E Elewski, Phoebe Rich, Richard Pollak, et al.
Journal of the American Podiatric Medical Association|September 22, 2006
Analgesic efficacy of valdecoxib for acute postoperative pain after bunionectomyRichard Pollak, Gary A Raymond, Richard M Jay, et al.
Vaccine|March 26, 2016
Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trialGuy de Bruyn, Jamshid Saleh, David Workman, et al.
The New England Journal of Medicine|August 15, 2014
Efficacy of high-dose versus standard-dose influenza vaccine in older adultsCarlos A DiazGranados, Andrew J Dunning, Murray Kimmel, et al.
Pageof 2